The Cooper Companies, Inc. (LON:0I3I)

Market Cap	10.53B -26.7%
Revenue (ttm)	3.03B +5.7%
Net Income	292.58M -3.4%
EPS	1.46 -3.0%
Shares Out	n/a
PE Ratio	36.00
Forward PE	15.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41
Average Volume	704
Open	74.73
Previous Close	71.42
Day's Range	70.60 - 74.73
52-Week Range	61.00 - 89.11
Beta	1.03
RSI	30.38
Earnings Date	Mar 5, 2026

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 15,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I3I

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Financial numbers in USD